Drug giant, Merck, lost its first battle in the Fosamax war. A jury in the US District Court for the Southern District of New York found that the osteoporosis drug was defectively designed and “unreasonably dangerous.”
The jury awarded $8 million in compensatory damages to a 72-year-old woman named Shirley Boles from Fort Walton Beach, Florida because Fosamax was found to have caused the disabling and disfiguring disease, osteonecrosis of the jaw. The plaintiff’s legal team was led by Tim O’Brien of the Levin, Papantonio Law Firm and was co-counseled by Gary Douglas of Douglas & London. Jim Green was also on the victorious legal team. According to Mr. O’Brien: : “This jury saw what we at Levin Papantonio saw in Ms. Boles. She’s the world’s bravest great-grandmother and this horrible injury never should have happened to her. But it did, so she took on a giant. And she won.”
If you or a loved one has suffered due to a defective drug, please contact an experienced defective drug attorney near you today to schedule a no-cost, confidential consultation. Personal injury attorneys work on a contingency basis, which means they do not get paid unless they win your case.